Detection of a Tumor-Associated Antigen in Breast Cancer
Author Information
Author(s): S.A. Imam, L.A. Mills, C.R. Taylor
Primary Institution: University of Southern California, School of Medicine
Hypothesis
The study aims to identify a tumor-associated antigen (TAA.62) that is expressed at elevated levels in malignant mammary epithelial cells compared to normal cells.
Conclusion
The study found that TAA.62 is expressed at higher levels in malignant mammary epithelial cells and may play a role in their proliferation.
Supporting Evidence
- TAA.62 was found to be expressed at elevated levels in malignant cells compared to normal cells.
- Binding of anti-TAA.62 antibody inhibited the proliferation of malignant cells but not normal cells.
- Scatchard analysis revealed 2.6 x 10^4 binding sites per cell for TAA.62.
Takeaway
Researchers found a special protein in breast cancer cells that helps them grow, but not in normal cells.
Methodology
The study used human monoclonal antibodies to purify and characterize the TAA.62 antigen from mammary epithelial cell lines.
Limitations
The study primarily focused on specific cell lines and may not represent all breast cancer types.
Want to read the original?
Access the complete publication on the publisher's website